180 Life Sciences Corp (ATNF)

180 Life Sciences Corp Azioni (ATNF) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-0.0015
Operating Expenses	58.95% 1.4525	3.5382	3.683	4.8038	5.6399
Interest Income/Expense	13.77% 0.01	0.0116	0.0116	0.0565	0.0143
Operating Income/Loss	58.95% -1.4525	-3.5382	-3.683	-4.8038	-5.6399
Nonoperating Income/Loss	102.44% 0.221	-9.0726	0.00281	0.0418	-17.05
Income/Loss From Continuing Operations Before Tax	90.23% -1.2315	-12.61	-3.6802	-4.7621	-22.69
Income Tax Expense/Benefit, Deferred	-0.00466	-	-	-	-
Income Tax Expense/Benefit	99.81% -0.00439	-2.345	-	-	-
Income/Loss From Continuing Operations After Tax	88.05% -1.2271	-10.27	-3.6802	-4.7621	-21.74
Net Income/Loss	88.05% -1.2271	-10.27	-3.6802	-4.7621	55.71
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	77.45
Basic Average Shares	166.40% -5.2797	7.952	5.2313	3.7471	-33.90
Basic Earnings Per Share	3,720% -49.28	-1.29	-0.70	-1.27	-19.91
Diluted Earnings Per Share	3,720% -49.28	-1.29	-0.70	-1.27	-18.08
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-